№ lp_2_1_23474
File format: docx
Character count: 2240
File size: 841 KB
Figure illustrating the masking strategy for immune spatial transcriptomics applied to melanoma samples to distinguish tumor regions from tumor microenvironment regions using immune-related gene expression and immunofluorescence patterns.
Year:
2025
Region / City:
Not specified
Subject:
Immune spatial transcriptomics, melanoma, immune cell analysis
Document Type:
Scientific figure description
Organization / Institution:
Not specified
Author:
Romano, G
Target Audience:
Researchers in immunology, oncology, and spatial transcriptomics
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Field:
Cancer research, spatial transcriptomics
Document type:
Supplementary data / Methods
Authors:
Sammy Ferri-Borgogno, Ying Zhu, Jianting Sheng, Jared K. Burks, Javier Gomez, Kwong Kwok Wong, Stephen T.C. Wong, Samuel C. Mok
Institution:
Unspecified (data from GEO database and previous publications)
Sample:
High-grade serous ovarian cancer patients
Techniques:
scRNA-seq, spatial transcriptomics, UMAP, PCA, GO enrichment analysis
Data source:
GEO database
Cell types analyzed:
Epithelial cells, fibroblasts, endothelial cells, T cells, B cells, myeloid cells, NK cells, dendritic cells, monocytes, macrophages
Analysis period:
Not specified
Methodology details:
Differential expression analysis, cluster annotation, ligand-receptor interaction assessment
Year:
2014
Region / City:
Burlington, Ontario, Canada
Topic:
Acoustic Network, Sound Masking, Paging Systems
Document Type:
Technical Specification
Organization / Institution:
K.R. Moeller Associates Ltd.
Author:
K.R. Moeller Associates Ltd.
Target Audience:
Specifiers, engineers, architects, and installation contractors
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Description:
Technical specification for LogiSon Acoustic Network, a networked sound masking, paging, and music system with detailed installation, product, and warranty information.
Year:
2023
Note:
Region / City
Theme:
Sound Masking Systems
Document Type:
Specification
Target Audience:
Contractors, Sound Masking System Designers, Architects, Project Managers
Year:
2020
Organization:
Centers for Disease Control and Prevention (CDC)
Document Type:
Competency Assessment Form
Target Audience:
Healthcare staff required to use surgical and N95 masks
Validation Type:
Return demonstration
Date of Issue:
07/16/2020
Scope:
Surgical and N95 respirator mask application and removal procedures
Evaluation Criteria:
Proper mask fit, hand hygiene compliance, correct donning and doffing techniques
Feedback Provided:
Immediate observation feedback with signature verification
Year:
1968
Region / City:
United Kingdom
Topic:
Vaccination, Measles, Immunology
Document Type:
Educational Text
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Students, Health professionals
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / City:
Liverpool
Topic:
Paediatric Health, Medical Conditions
Document Type:
Information Leaflet
Author:
Unknown
Target Audience:
Parents and carers of children diagnosed with ITP
Period of Validity:
Until February 2028
Approval Date:
Unknown
Review Date:
February 2028
Year:
Not specified
Region / City:
Not specified
Theme:
Immunology
Document Type:
Research Project Description
Institution:
Nanyang Technological University (NTU)
Author:
Asst Prof Loh Jia Tong
Target Audience:
Not specified
Duration:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2021
Region / city:
Canada
Topic:
Rh Immunization Prevention
Document Type:
Guidelines
Organization / Institution:
CSTM
Author:
Not specified
Target audience:
Healthcare professionals (Physicians, Midwives, Technologists)
Period of validity:
Ongoing
Approval date:
2021
Revision date:
July 15, 2021
Changes date:
August 8, 2014
Standard:
AABB 29th Standards 5.30
Thema:
Rh Immune Globulin prophylaxis
Dokumenttyp:
Transfusionsrichtlinie
Fachbereich:
Transfusionsmedizin
Betroffene Patientengruppe:
Rh negative Patientinnen und Patienten
Zielgruppe:
Schwangere Frauen und transfusionsmedizinische Dienste
Schwangerschaftszeitraum:
Pränatal, ≥20 Wochen Gestation, ≤20 Wochen Gestation, postpartal
Testverfahren:
ABO-Typisierung, Rh-Typisierung mit Weak D, Antikörpersuchtest, Fetalscreen Rosette-Test, Flow Cytometry Hemoglobin F, Kleihauer Betke Fetal Stain
Dosierung:
300 Mikrogramm Rh Immune Globulin pro Standarddosis
Berechnungsgrundlage:
Prozent fetaler Zellen × 50, Division durch 30 ml Vollblut pro Dosis
Indikation:
Exposition gegenüber Rh positiven Erythrozyten
Besondere Hinweise:
Fetalscreen nur gültig bei >20 Wochen und DAT negativem Neugeborenen
Year:
2023
Region / City:
Wuhan, China
Topic:
Immunology, Cancer Research, Gene Expression, Immunotherapy
Document Type:
Research Article
Institution:
Wuhan University of Science & Technology, Huazhong University of Science and Technology, Anhui Normal University
Authors:
Fei-Fei Hu, Chun-Jie Liu, Lan-Lan Liu, Qiong Zhang, An-Yuan Guo
Target Audience:
Researchers, Healthcare Professionals, Academics in Immunology and Oncology
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Revision:
N/A
Year:
2023
Region / City:
Not specified
Topic:
Immunology, Cytotoxicity, Flow Cytometry
Document Type:
Research Supplementary Figures
Author:
Not specified
Target Audience:
Researchers, Immunologists
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / City:
Los Angeles, CA, USA; Prague, Czech Republic; New Orleans, LA, USA; Birmingham, AL, USA; State College, PA, USA; Ithaca, NY, USA; Chengdu, China
Topic:
Extracellular Vesicles, Stem Cells, Immune Modulation, Diabetes Therapy
Document Type:
Research Supplementary Figures
Institution / Organization:
University of California, Los Angeles, University of California, Los Angeles, Tulane University, University of Alabama at Birmingham, Pennsylvania State University, Cornell University, Sichuan University
Author:
Jana Zarubova, Mohammad Mahdi Hasani-Sadrabadi, Yutong Wu, Graciel Diamante, Jenny Cheng, Xiao Han, Fatemeh Sadat Majedi, Li Yang, Olivia Wang, In Sook Ahn, Jianyi Zhang, Xiaojun Lance Lian, Zhen Gu, Manish J. Butte, Reza Ardehali, Peter C Butler, Tony Ye Hu, Louis-S. Bouchard, Xia Yang, Song Li
Target Audience:
Researchers in stem cell biology, regenerative medicine, diabetes therapy
Period of Effect:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Description:
Research supplementary material focusing on extracellular vesicles derived from pluripotent stem cells and their role in immune modulation for diabetes treatment, including experimental figures and lipid profiles.
Year:
2017
Region / City:
N/A
Theme:
Immune System, Pathogens, Immunity
Document Type:
Educational Chapter
Organization / Institution:
McGraw-Hill
Author:
McGraw-Hill Biology
Target Audience:
Students, General Public
Duration:
N/A
Approval Date:
N/A
Modification Date:
N/A
Authors:
Jianhua Rao; Jiannan Qiu; Ming Ni; Hao Wang; Peng Wang; Lei Zhang; Zeng Wang; Mu Liu; Feng Cheng; Xuehao Wang; Ling Lu
Affiliations:
Hepatobiliary Center of The Affiliated Cancer Hospital (Jiangsu Cancer Hospital) and The First Affiliated Hospital, Nanjing Medical University; Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment; Collaborative Innovation Center for Personalized Cancer Medicine; State Key Laboratory of Reproductive Medicine
Institution:
Nanjing Medical University
Country:
China
Type of Document:
Supplementary Material
Discipline:
Immunology; Hepatology; Molecular Biology
Subject:
Role of macrophage Nrf2 deficiency and Timp3-mediated RhoA/ROCK pathway in ischemic liver injury
Experimental Models:
Mouse models; Bone marrow–derived macrophages (BMMs); Hepatic macrophages
Methods:
Cell isolation and culture; Biochemical measurements; Histopathology; Immunohistochemistry; Immunofluorescence; TUNEL staining; MDA, GSH and MPO assays; Western blotting; qRT-PCR; ELISA; RNA sequencing; Chromatin immunoprecipitation
Correspondence:
Ling Lu; Xuehao Wang; Feng Cheng
Equal Contribution:
Jianhua Rao; Jiannan Qiu; Ming Ni
Year:
2023
Region / City:
Queenstown, New Zealand
Topic:
Immune therapies, cancer treatment, cell and gene therapy
Document Type:
Event Description
Organization / Institution:
International Society for Cell and Gene Therapy (ISCT), Liger Leadership Academy
Authors:
Emily Blyth, Alicia Didsbury
Target Audience:
Researchers, medical professionals, general public interested in immune therapies
Date of Approval:
August 5, 2023
Date of Changes:
N/A
Program:
Medicare IVIG Demonstration
Administering Agency:
Centers for Medicare & Medicaid Services (CMS)
Country:
United States
Legal Basis:
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Extended Under:
Disaster Tax Relief and Airport and Airway Extension Act of 2017
Further Extension:
Consolidated Appropriations Act, 2021
OMB Control Number:
0938-1246
CMS Form Number:
CMS-10518
Subject:
Application for beneficiary participation in the IVIG Demonstration
Target Population:
Medicare Part B beneficiaries with primary immune deficiency disease (PIDD)
Enrollment Cap:
6,500 beneficiaries (originally 4,000)
Funding Limit:
$45 million including administrative and evaluation costs
Coverage Scope:
Bundled payment for medically necessary supplies and services for in-home IVIG administration
Application Requirement:
Mandatory signed application by beneficiary and provider
Submission Methods:
Mail or fax
Languages Available:
English and Spanish
Period of Demonstration:
Through December 31, 2023 or until statutory limits are met
Participation Status:
Voluntary; may be terminated by beneficiary at any time
Institution:
Centrum Medische Genetica UZ Gent
Document type:
Clinical checklist
Subject:
Primary immune deficiency (PID) gene panel analysis
Legal reference:
Artikel 33, K.B. 10.11.2012 (in werking 1.1.2013)
Regulatory authority:
Recognized clinical geneticist validation requirement
Target group:
Referring physicians and clinical geneticists
Required information:
Patient identification, PID classification, clinical manifestations, screening results, familial history
Classification system:
International Union of Immunological Societies (IUIS) Expert Committee
Purpose:
Submission of clinical data for PID panel request validation
Fields included:
Patient name, date of birth, referring physician, RIZIV number, clinical indications, laboratory and genetic screening results